Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients

NCT00688454 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00688454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00688454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 28, 2007
Completion date
January 31, 2008
Enrollment
3,392 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesteremia